Story of claim

Doctor Adam Bataineh warns against testosterone replacement therapy for individuals without a hormone deficiency due to potential increased risks of heart disease and cancer. He emphasizes that TRT should be reserved for those with true deficiencies, as hormone-sensitive cancers like breast and prostate cancer may be affected.

• Goal: To highlight potential risks of hormone therapy in non-deficient individuals.
• Proof: Adam Bataineh cites increased heart disease and cancer risks as potential consequences of unnecessary hormone therapy.
• Nuances:
  • TRT recommended only for true deficiency
  • Breast and prostate cancer sensitive to hormones
  • Hormone replacement therapy improves quality of life
• Impact on Life: Avoiding unnecessary TRT may prevent long-term health complications related to heart and cancer risks.